[研究报告] 2023 年雾化器市场价值为 8.1588 亿美元,预计到 2031 年将达到 13.1557 亿美元;预计 2023-2031 年期间的复合年增长率为 6.2%。
市场洞察和分析师观点:
雾化器市场 预测是基于各种二手和一手研究来源的结果得出的。
雾化器是一种用于输送各种药物的设备,有助于控制喘息等呼吸问题并稀释肺部分泌物。它将液体药物转化为细小的液滴,然后通过面罩或口含器吸入,药物可以通过面罩或口含器直接进入肺部。与其他吸入器不同,雾化器使用由插座供电的空气压缩机。
影响雾化器市场增长的驱动因素和限制因素
近年来,由于技术的进步和产品的小型化,家庭医疗保健设备越来越受欢迎。这导致家庭医疗保健设备的采用率上升。此外,老年人口的不断增长、慢性肾病发病率的高涨以及医疗服务和住院费用的不断上涨,导致越来越多的人倾向于在家庭护理环境中治疗患者。家庭医疗保健是一种经济实惠的替代昂贵住院治疗的方法,因为市场上有适合家庭使用的紧凑、便携、患者友好的雾化器,再加上降低噪音和改善功能的技术创新。此外,雾化制剂中还有多种药物,包括长效β2-激动剂 (LABA)、长效毒蕈碱受体拮抗剂、类固醇、抗生素和粘液溶解剂。最近在市场上推出的一些家用产品如下:
- 2023 年 1 月,Synergy Life Science, Inc. 推出了 Nebi,这是一款袖珍型雾化器,采用电池供电,适用于各种应用。
- 2021 年 7 月,HCmed Innovations 获得美国食品药品监督管理局 (FDA) 批准生产 Pulmogine 振动网状雾化器。该设备便携且易于使用,是需要吸入治疗患者的便捷解决方案。
- 2020 年 6 月,Respira Technologies, Inc. 推出了 RespiRx 药物输送设备平台。该新型平台是一款超便携手持式振动网状雾化器 (VMN),用于局部和全身治疗各种目标适应症,包括哮喘和 COPD。
这些发展已将雾化器的使用范围从诊所或医院的急性护理环境扩展到家庭护理环境。
然而,社区对哮喘缺乏认识和认知、医疗保健服务难以获得、医疗系统紧张、缺乏诊断测试(包括肺量计)、医疗保健提供者缺乏培训以及未实施哮喘指南都是导致哮喘漏诊的主要因素。哮喘漏诊进一步导致患者服用错误药物治疗其病情,临床效果不佳,这反过来又会阻碍市场增长。尽管哮喘在世界范围内的患病率不断上升,但人们对这种疗法的接受度却较低,因为人们更倾向于使用阿育吠陀和自制药物。治疗哮喘和慢性阻塞性肺病 (COPD) 的指南发生了重大变化。吸入皮质类固醇 (ICS) 单独使用或与长效 β2-激动剂 (LABA) 联合使用是哮喘的一线治疗,而长效毒蕈碱拮抗剂单独使用或与 LABA 联合使用是 COPD 的一线治疗。由于这些特定的组合,先进便携式雾化器的成本有所上升。根据 Pubmed Central 2020 年 9 月发表的一篇文章,进行了一项研究,以评估在实际环境中静脉注射甲基强的松龙和雾化布地奈德治疗慢性阻塞性肺病急性加重期 (AECOPD) 的成本效益。该研究得出结论,与静脉注射甲基强的松龙相比,雾化布地奈德对中国的 AECOPD 患者不是一种具有成本效益的治疗方法。因此,缺乏早期诊断和雾化治疗的高成本阻碍了雾化器的发展。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
报告细分和范围:
“2031 年全球雾化器市场分析”是一项专门的深入研究,侧重于全球市场动态,以帮助确定市场中的关键驱动因素、未来趋势和有利可图的机会,进而有助于确定主要的收入来源。该报告旨在提供市场概况,并按类型、应用和最终用户对市场进行详细细分。雾化器市场报告的范围包括北美(美国、加拿大和墨西哥)、欧洲(西班牙、英国、德国、法国、意大利和欧洲其他地区)、亚太地区(韩国、中国、印度、日本、澳大利亚和亚太地区其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
节段分析:
根据类型,市场细分为喷射雾化器、超声波雾化器和网状雾化器。喷射雾化器细分市场在 2022 年占据了最大的市场份额。网状雾化器细分市场预计将在 2023-2031 年期间实现最高复合年增长率。喷射雾化器是一种价格合理且易于使用的设备,以气溶胶形式输送药物。它们设计为一次性使用,无需消毒并降低了污染风险。喷射雾化器通常用于机械通气。这些雾化器在 CRD 治疗中的各种应用正在推动预测期内喷射雾化器市场规模的增长。
根据应用,市场细分为 COPD、哮喘、囊性纤维化等。预计 COPD 细分市场将在 2023 年占据最大的雾化器市场份额。预计哮喘细分市场在 2023-2031 年期间的复合年增长率最高。COPD 是一种慢性炎症性肺部疾病,会导致肺部气流受阻。症状包括呼吸困难、咳嗽、产生粘液(痰)和喘息。它通常是由长期接触刺激性气体或颗粒物引起的,最常见的是香烟烟雾。患有 COPD 的人患心脏病、肺癌和其他多种疾病的风险较高。根据世界卫生组织 (WHO) 的数据,COPD 是全球第三大死亡原因。随着呼吸系统疾病负担的增加,对吸入疗法的需求也在增加。此外,对家庭护理治疗的偏好转变推动了手持式雾化器在 COPD 和哮喘管理中的应用。
根据最终用户,雾化器市场分为医院和诊所、急救中心和家庭护理环境。医院和诊所部分在 2023 年占据了最大的市场份额,预计在 2023 年至 2030 年期间将实现最高的复合年增长率,这得益于各种类型的雾化器的医疗可用性以及这些设备在医院环境中的采用率不断提高。
区域展望:
2023 年,北美占据了雾化器市场的最大份额。2023 年,美国占据了该地区最大的市场份额,其次是加拿大,原因是该地区人群中 COPD 和哮喘的患病率不断上升。根据《默克夏普和多姆 (MSD) 手册》发表的一篇文章,约有 1600 万人患有 COPD,这是一种主要的死亡原因,每年在美国夺走超过 15 万人的生命。推动北美雾化器市场增长的其他因素包括医疗保健领域先进设备的引入、医疗保健支出的增加以及该地区领先的市场参与者的存在,包括 OMRON Healthcare、BD 和 GE Healthcare。
雾化器市场区域洞察
Insight Partners 的分析师已详尽解释了预测期内影响雾化器市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的雾化器市场细分和地理位置。
- 获取雾化器市场的区域特定数据
雾化器市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | 8.1588亿美元 |
2031 年市场规模 | 13.1557亿美元 |
全球复合年增长率(2023 - 2031) | 6.2% |
史料 | 2021-2023 |
预测期 | 2023-2031 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
雾化器市场参与者密度:了解其对业务动态的影响
雾化器市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在雾化器市场运营的主要公司有:
- 欧姆龙医疗公司
- 荷兰皇家飞利浦公司
- 帕里有限公司
- Vectura 集团有限公司
- 驾车前往 DeVilbiss International
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 获取雾化器市场顶级关键参与者概述
行业发展和未来机遇:
根据公司新闻稿,全球雾化器市场主要参与者采取的一些举措如下:
- 2021 年 12 月,西普拉有限公司 (Cipla Limited) 推出了一项计划,旨在利用其在整个护理过程中的广泛影响力以及广泛的药物-设备组合和治疗方法,改善印度农村初级医疗中心获得治疗急性哮喘的雾化治疗的机会。
- 2021 年 3 月,PARI Pharma GmbH 推出了其 LAMIRA 雾化器系统,该系统已获准在日本提供 ARIKAYCE(阿米卡星脂质体吸入混悬液)。该系统采用基于 eFlow 技术的先进气雾剂输送系统,并配有可容纳 8.4 毫升全剂量的定制药物储存器。
- 2021 年 3 月,欧姆龙医疗公司 (OMRON Healthcare, Inc.) 与美国哮喘和过敏基金会 (AAFA) 合作提供医用级雾化器,以支持 AAFA 的宣传和计划,传播帮助哮喘社区中最脆弱成员的意识。
竞争格局和重点公司:
OMRON Healthcare, Inc.;Koninklijke Philips NV;PARI GmbH;Vectura Group Ltd;Drive DeVilbiss International;Briggs Healthcare;GF Health Products, Inc.;GE Healthcare;Agilent Technologies, Inc.;Terumo Corporation;以及 Trudell Medical International 是雾化器市场报告中介绍的知名公司。这些公司专注于新技术、现有产品的改进和地域扩张,以满足全球日益增长的消费者需求。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The nebulizers market was valued at US$ 815.88 million in 2023.
Key factors driving the nebulizers market growth are the surging prevalence of chronic respiratory diseases and increasing demand for respiratory devices for home care settings are driving the growth of the market.
A nebulizer is a device used to deliver various medicines to help control breathing problems such as wheezing and loosen lung secretions. It converts liquid medicine into fine droplets, which are then inhaled through a mask or mouthpiece through which the medicine can enter directly into the lungs. Unlike other inhalers, nebulizers use an air compressor powered by electricity from an outlet.
Based on type, the market is segmented into jet nebulizers, ultrasonic nebulizers, and mesh nebulizers.
The nebulizers market majorly consists of the players, including Baxter; B. Braun Medical Inc.; BD; Cantel Medical; DaVita Inc.; Fresenius Medical Care; Medtronic; Nikkiso Co., Ltd.; Asahi Kasei Corporation; and Terumo Corporation.
The nebulizers market is expected to be valued at US$ 1315.57 million in 2031.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Nebulizers Market
- OMRON Healthcare, Inc
- Koninklijke Philips N.V.
- PARI GmbH
- Vectura Group Ltd
- Drive DeVilbiss International
- Briggs Healthcare
- GF Health Products, Inc.
- GE Healthcare
- Agilent Technologies, Inc
- Terumo Corporation
- Trudell Medical International
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.